Lexicon Pharmaceuticals (LXRX) Net Cash Flow: 2009-2024
Historic Net Cash Flow for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to $44.2 million.
- Lexicon Pharmaceuticals' Net Cash Flow fell 93.80% to $9.7 million in Q4 2012 from the same period last year, while for Dec 2012 it was -$155.9 million, marking a year-over-year decrease of 212.07%. This contributed to the annual value of $44.2 million for FY2024, which is 285.05% up from last year.
- Latest data reveals that Lexicon Pharmaceuticals reported Net Cash Flow of $44.2 million as of FY2024, which was up 285.05% from -$23.9 million recorded in FY2023.
- In the past 5 years, Lexicon Pharmaceuticals' Net Cash Flow ranged from a high of $90.2 million in FY2020 and a low of -$62.2 million during FY2021.
- Moreover, its 3-year median value for Net Cash Flow was -$17.7 million (2022), whereas its average is $863,667.
- In the last 5 years, Lexicon Pharmaceuticals' Net Cash Flow soared by 303.62% in 2020 and then slumped by 168.99% in 2021.
- Yearly analysis of 5 years shows Lexicon Pharmaceuticals' Net Cash Flow stood at $90.2 million in 2020, then slumped by 168.99% to -$62.2 million in 2021, then surged by 71.51% to -$17.7 million in 2022, then tumbled by 34.76% to -$23.9 million in 2023, then spiked by 285.05% to $44.2 million in 2024.